1.1400
+0.0100
+(0.88%)
At close: April 17 at 4:00:01 PM EDT
1.0772
-0.06
(-5.51%)
After hours: April 17 at 6:31:36 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 3 |
| Avg. Estimate | -0.12 | -0.15 | -0.61 | -0.76 |
| Low Estimate | -0.14 | -0.16 | -0.64 | -0.87 |
| High Estimate | -0.09 | -0.15 | -0.58 | -0.67 |
| Year Ago EPS | -0.24 | -0.15 | -1.71 | -0.61 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 4 |
| Avg. Estimate | 3.55M | 3.62M | 14.38M | 14.4M |
| Low Estimate | 600k | 600k | 2.6M | 900k |
| High Estimate | 9.7M | 10M | 40.7M | 44.7M |
| Year Ago Sales | 2.4M | 2.77M | 18.72M | 14.38M |
| Sales Growth (year/est) | 48.04% | 31.06% | -23.18% | 0.14% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.32 | -0.2 | -0.01 | -0.38 |
| EPS Actual | -0.24 | -0.15 | -0.11 | -1.01 |
| Difference | 0.08 | 0.05 | -0.1 | -0.64 |
| Surprise % | 24.53% | 24.37% | -1,275.00% | -169.33% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.12 | -0.15 | -0.61 | -0.76 |
| 7 Days Ago | -0.12 | -0.15 | -0.61 | -0.76 |
| 30 Days Ago | -0.14 | -0.15 | -0.6 | -0.7 |
| 60 Days Ago | -0.21 | -0.23 | -0.57 | -0.75 |
| 90 Days Ago | -0.21 | -0.23 | -0.51 | -0.69 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACRS | 50.00% | -2.22% | 64.47% | -25.10% |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/18/2025 |
| Initiated | Scotiabank: Sector Outperform | 3/7/2025 |
| Upgrade | HC Wainwright & Co.: Neutral to Buy | 12/23/2024 |
| Upgrade | Leerink Partners: Market Perform to Outperform | 11/19/2024 |
| Upgrade | Jefferies: Hold to Buy | 11/19/2024 |
| Upgrade | BTIG: Neutral to Buy | 11/19/2024 |
Related Tickers
VCYT Veracyte, Inc.
31.14
-1.24%
SHC Sotera Health Company
10.48
-0.10%
NDRA ENDRA Life Sciences Inc.
3.6700
+8.90%
ISPC iSpecimen Inc.
1.2350
-6.44%
IJF.MU Icon PLC
127.30
0.00%
NRC.SG Neuronetics Inc
3.2450
+2.37%
MEDP.MX Medpace Holdings, Inc.
5,869.75
0.00%
NOTV Inotiv, Inc.
1.6400
-0.61%
DIA.WA Diagnostyka S.A.
148.20
+0.14%
LO3A.F Lonza Group AG
58.00
+2.65%